The timing of Chinese approval is up to the Chinese government (not AMRN.) I wonder if Edding was a good choice or not. Strange how AMRN avoided the selection of any BP as a partner...Instead they went with Kowa (which was a waste of money) they selected HLS for Canada (which had no Cardiovascular sales force.) Imagine had they had selected Pfizer for any of those three! What I thought was really ironic was when Adam Feuerstein suggested that Thero was "tired" and that he should sell the company to BP. AF said he could become a "wall street hero" if he sold the company...then Thero decided to hire GS/MS not to sell the company but to raise money to expand the sales force. Too bad for Thero (and for us) that he did not heed AF's advise. Instead of becoming a wall street hero Thero is now a wall street zero.
News 
Market Data 
Discover 
AI
